Endometriosis Trial, Recruiting NCT06209346 Sponsor: University of Alcala Condition: Endometriosis
Back to Endometriosis

Endometriosis Trial, Recruiting

NCT06209346
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a woman who has been officially diagnosed with endometriosis by a doctor.
  • You are between 18 and 55 years old.
  • You are currently receiving or have previously received medical and/or surgical treatment for endometriosis, and your condition is considered under control.
  • You have had ongoing pelvic pain for at least 3 months.
  • Your pain level is greater than 4 out of 10 on a pain scale.
  • You are able to read and understand information provided to you and can sign a consent form freely and without difficulty.
  • You have access to an electronic device such as a tablet, computer, or mobile phone.
  • You have an active, valid email address.

Who may not be able to join:

  • Women who are going through or have already gone through menopause.
  • Women who are currently pregnant or are planning to become pregnant during the study period.
  • Women who have a history of gynaecological cancer or are currently receiving any cancer treatment in the pelvic or pelvic floor area.
  • Women who have been diagnosed with chronic fatigue syndrome or fibromyalgia.
  • Women who are already taking part in another clinical intervention study at the same time.
  • Women who are planning to have surgery during the study period.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 918856875

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Alcala
Registry
ClinicalTrials.gov
Start date
27 November 2023
Est. completion
17 January 2025

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Health Status Questionnaire (SF-12); Visual Numeric Scale (VNS); Endometriosis Health Profile (EHP-30); Index of Sexual Function (IFSF); Tampa Scale of Kinesiophobia (TSK); Pain Catastrophizing Scale (PCS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov